Member Info for PDMSPiper

Lots of dunces about who would do better to keep their money in the post office for sherbet dips and curly wurlies rather than trying to make smart arsed assessments of immunity and diagnostics.
I posted an in depth scientific study paper earlier today that clears this misinformation up.
Better to read the conclusions of the scientists rather than some clueless numpty with a CSE in gardening pretending to be a world authority on epidemiology.

“A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease“

“Key findings:
We have presented a broad, comprehensive review of multiple aspects of the literature on antibody immunity to coronaviruses. We identified a number of key findings. The median time to detection was similar across different antibodies for SARS-CoV-1 (12 days; IQR 8-15.2 days) and SARS-CoV-2 (11 days; IQR 7.25-14 days), but longer for MERS-CoV (16 days; IQR 13-19 days). Most long-term studies found that IgG waned over time (typically detectable up to at least a year) while others found detectable levels of IgG three years post symptoms onset. Antibody kinetics varied across the severity gradient with longer durations of detectable antibody associated with more severe symptoms. Human challenge studies with HCoV indicate that serum and mucosal immune responses (serum IgG, IgA, neutralizing titer, mucosal IgA) provide possible correlates of protection from infection and disease. However, repeat human challenge experiments with single HCoV suggest individuals can be infected with the same HCoV one year after first challenge, but with possible lower severity. There is cross-reactivity within but minimal reactivity between Alpha- and Beta-CoVs. While endemic HCoVs rarely induce cross-reactive antibodies against emerging HCoVs, SARS-CoV-1 and MERS-CoV stimulate antibodies induced by prior HCoV infections.”

https://www.medrxiv.org/content/10.1101/2020.04.14.20065771v1.full.pdf

Agreed. Big blue FOMO Friday afternoon coming as forecast.

Design Freeze RNS is likely to be Intraday as was the last RTC progress update by Abingdon.
Could land anytime.
The situation regarding the share price consolidation and at the end of channel looking to break out again is now the same as it was immediately before Colins Sky news interview.

If the DF RNS lands intraday or even a bullish Abingdon update or similar then that could trigger an explosive breakout similar to what we saw after the sky news interview and this time there’ll be no speeding ticket. The MMs have been accumulating and ready for it. They’ve made their piece of the pie by shorting the drop on the speeding ticket. They covered that and now they’ve been buying back and are ready to make another killing letting us go up.
It won’t take much to break explosively out of this range.
Could be this afternoon, could be Monday. Let’s see.

GLA.

Omegas Private RTC partner Abingdon Health see the design freeze announcement as a foregone conclusion and are already planning to move into the next phase of rapid fast track verification and scale up into manufacture. This from their press release 3rd June.

Chris Yates, CEO of Abingdon Health, commented:

“We are delighted with the progress made to date and are working hard to bring a quality home test at scale to the UK public. We have an excellent team of scientists and I would like to thank them for their dedication and hard work in getting the project to where it is today. We now move onto the next phase of this project and working with our partners in the consortium ensures we are able to scale the product to the desired volume quickly.“

I can see a big blue afternoon here today. Big market sell off today and could also be a morning shake here but we’ll be blue this afternoon.

The noisy neighbors AVCT have started talking about cancer treatments and they’re not expecting and news on their Covid tests until after Summer. Looking at September so probably a sell off to sub 1.20 placing price there when that realization sinks in and a lot of that money coming here.

Ignore the FUD and noise about other home tests. They’ve all been rejected. The bar for confident testing of whole populations is 98% and none of them meet it. Ours will be 99%+, as good as a lab test, as good as humanly possible. The only home test in the world as good as a lab test.
That’s what the governments waiting for and that’s why we’re here.

Perfect storm brewing for Omega here. This is the place to be. Money flooding in here from today.

GLA. DYOR.

Owners of Zara announce they will close up to 1200 fashion retail stores worldwide. Reality check.....

https://www.theguardian.com/business/2020/jun/10/zara-owner-to-close-up-to-1200-fashion-stores-around-the-world

Money will be flooding in here in the next couple of weeks if not before.
That spoofy market recovery lasted all of about 3 days.
Blood everywhere today, oilers, miners, builders etc all tanking.
Carnival cruises down 11%, EasyJet down 6%, AA down 6%, j wood grp down 10%, SHI down 5%, Shell, Bp, PMO, Tullow all down.
The sheet is hitting the fan earlier than I thought.

Reality will set in soon. There’ll be a big exit of cash from Dodgey looking stocks who are sacking staff and struggling to stay afloat. That money needs a home and little Omega Diagnostics will be centre if attention and all over the news and the front pages.

All looking like a lovely little perfect storm brewing here for us. Cushty.

GLA.

ODX are not a charity.

The company will not be using up valuable production assets and time producing tests for Mologic on the cheap because they’re a charity outfit. That’s the point.

They haven’t just ditched the antigen business to help Mologic in their charitable endeavors.

The point I’m making is, whatever Mologic want to do with their portion of the tests, ie sell them cheap or give them away, will not affect the price that Omega gets paid to produce them.

Omega are not a charity.

1.) The price that Mologic charge for the tests at retail should have no bearing on what ODX get paid for manufacture. ODX will charge a cost plus margin fee and Mologic can give them away if they like. Who cares.

2.) The Elisa Mologic test is highly accurate. “As good as humanly possible”. It’s got a CE mark and according to the Mologic website their strategy is to market it to the uk.

Omega/Mologic partnership will be very fruitful going forward. The company will sell all tests at maximum capacity.
Capacity has already been increased at Alva and plans in place to increase capacity over two sites to approximately 50Million tests per annum...

“Our current capacity for lateral flow tests at Alva is 100,000 tests per week. We are currently in the process of increasing that to 200,000 tests per week and looking at options to further increase to 500,000 tests per week.

Our capacity in Littleport is currently just under 50,000 tests per day. We are currently looking to increase that to 100,000 per day.

We only have two manufacturing sites.”

I sold out of RBD on the drop between the 70s and 50s, well before Covid. I made a very detailed final post with my trades and why.
I only ever traded UJO, in and out. Crap company.
They still haven’t got their EWT as I correctly predicted and still no drilling of WNB1 either as predicted.
Personally I think RBD is no more than a financial instrument to filter back the £30million owed by Rathlin to Connaught. Not expecting anything to come of West Newton.
I was happy with my exit of RBD at the right time. I doubled my money on tlw from 13 to 26p and sold out the Thursday before Easter and the opec meeting.
Bought in here shortly after with first buys at 17p.

I’m doing fine thanks older. Oops. Ya bell end.

Now hop off back to Avacta and pray that they can get those affirmers working on something to support that toppy Mcap. It’s gotta work on something for gods sake. Anything. Lordy.

All good here. Selling products, products are tested and assessed to work so I’m very happy. Won’t be going near oilers until at least next year.

Very informative article all about the partnership between Omega and Mologic with the background story and an interview with Colin King CEO. It’s from April but all still very relevant.....

“King claims the Omega-Mologic antibody test is as close to perfection as humanly possible, with 98% accuracy — citing a successful collaboration as the reason, given the raw materials used to make them must be of high enough quality to return such results.”

https://www.nsmedicaldevices.com/analysis/uk-covid-19-antibody-testing/

The Elisa test is already CE marked and being assessed by Public Health England, PHE. Matt Han**** actually said in one of the briefings that they were assessing an Elisa antibody test. Mologic fully intend to market their Elisa tests for commercial sale in Europe. Could still be sold into U.K. ....

“Dr Joe Fitchett, Medical Director, Mologic: “Alongside the Liverpool School of Tropical Medicine and St George’s, University of London we launched a radically open, responsive, and rapid validation model to accelerate the submission of our COVID-19 diagnostics to Public Health England and for regulatory approval. Our laboratory and point-of-need tests will allow individuals to detect whether they have antibodies to COVID-19 and bring us one step closer to improving access to high quality diagnostics.”

https://mologic.co.uk/mologic-launches-new-lab-based-covid-19-antibody-tests/

First paragraph should read...

“Essential to get the news out of the £8Million write off out of the way now and set out that the business plan going forward to utilize all capacity...”

Sleepy eyes and iPhone. :-/

So that’s the preparatory clearing the decks RNS done. Essential to get the news out of the £8Million write off of the now and set out that the business plan going forward is to utilize all capacity and energy within the business to maximum effect.

The Mologic Elisa test is over the 98% accuracy bar for testing whole populations. Colin has already said it’s “as good as humanly possible”. It has a CE mark. It was being assessed by PHE. Mologic we’re looking to get it sold into the UK and it still could be. I feel sure it will be marketed in EU and USA. It’s a great product. It isn’t just for Africa. That’s the Mologic poc test. The poc test only achieved 96% accuracy so won’t get marketed in Europe but it will be a low cost option for third world countries, supplied at cost by Mologic or even free. Either way, ODX are not a charity and will be paid cost+margin to produce it. The Elisa test is not just for charity third world markets. If it was just for Africa they wouldn’t have bothered to CE mark it. The Mologic Elisa test could well be a very successful product in a global market and 46,000 per day at a few quid margin is not insignificant. It’s a lot of potential.

Apart from that the decks are now cleared for release of the big news on the RTC poc test design freeze and probably more details of gov pre orders and how much capacity the company will be using to make it. Design freeze is basically the first stage of going into production so we should get a lot of info about preparation for production. Possibly even some info on functionality, how it will link up with the app and how the entire system will work etc, possibly.

So the decks are cleared. The market makers have accumulated millions worth of cheap stock so they can let the sp run up unhindered while offloading it and making a killing.

All primed to go. Expecting the design freeze RNS within days. The company probably already know exactly when the news will be released hence the “clearing the decks” RNS. Shouldn’t be long now.

GLA. DYOR.

“. I may call it a day here at £1 “

SP is currently 52p and you’re forecasting £1. I’d call that a strong buy then but your post is mainly Whiney FUD.
Very strange and contradictory to say the least.

If you sold ODX today and bought this phoney unsupportable wider market recovery then that was exactly the opposite of the correct strategy to be employed now.

You should be selling out of the market recovery and buying ODX today.

That will become clear over coming weeks and a lot will be kicking themselves very soon, by the end of July all this will be just historical noise and the landscape will look very different.

Continue to hold and fully loaded. Strong buy all day.

GLA and DYOR.

This manufacturing agreement with Mologic is for three years, not “a couple”.

The Mologic poc test failed the gov bar at only 96% accuracy but it has its uses and will be marketed around the world. This is NEW business for us.

The Elisa test is a different kettle of fish. We knew we would be making 46,000 per day of these but we didn’t know for how long. Now we know it’s for 3 years! Up to 46k per day for 3 years. The Elisa test has CE mark and could see us in the UK, US and EU. It’s been assessed as being “as accurate as humanly possible”, and we are making 46k of it for 3 years. Boom. Lol.

GLA.

That’s very nice of you to say so Maya’s dad but please remember that everything posted on these boards is only opinion and my opinion has as much chance of being wrong as anybody else’s.

That’s why it’s important to always do lots of your own research.

Good luck all holders.

Any potential merger between Astra Zeneca and Gilead is of interest only to shareholders in those companies.
That won’t affect Omega Diagnostics one bit. Idiotic to try and suppose it would.
Pharma and biotech/diagnostics are not even the same industry.

If antibodies don’t provide protection or immunity then there’s no point producing a vaccine.

They don’t want hero johnnies who have had Covid to start running round refusing to obey any rules because they are “immune”. Chaos would ensue. They need everyone singing from the same sheet so for now the official line is that there’s no immunity.
In my opinion that will change over coming months. As investors we have to look at the strategy, the bigger picture and read between the lines to see where it’s going.
Sometimes, all is not as it seems.